Year: 2023

StrategyShare is Oct. 25 — a chance to get fresh ideas and win prizes

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention

A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes.

SHARE Center webinar, “What can you do? Stepping Up to Stop Workplace Violence and Sexual Harassment,” is Nov. 9

Wesley Self, MD, MPH

How biostatistics saves lives: the Vanderbilt experience

Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.

Sexual Harassment Awareness, Response, and Education (SHARE) Center overview of workplace violence is Oct. 19

New Refusal of Care Policy to be effective Nov. 15

1 19 20 21 22 23 107